Sarcoma | Tumor

With a Little Help from My Friends

January 19th 2020, 8:00pm

Article

Having loved ones by your side is right up there in importance with any aspect of healing from cancer.

All the Answers

January 7th 2020, 10:00pm

Article

Thoughts on New Year's resolutions and planning for the years ahead when your future is tied up in uncertainty because of cancer.

Friday Frontline: Cancer Updates, Research and Education on December 20, 2019

December 20th 2019, 9:00pm

Article

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

Triumph Over Cancer: Riding 'Coast 2 Coast'

October 17th 2019, 5:00pm

Podcast

Now a 10-year survivor of bone cancer, Dana Vaughns chose to triumph over his disease and joined Bristol-Myers Squibb on its Coast 2 Coast 4 Cancer ride.

Ten-Year Bone Cancer Survivor Rides 'Coast 2 Coast'

September 20th 2019, 1:00am

Article

Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.

Studying Rare Diseases Is Difficult, But Innovation Drives Results

August 30th 2019, 7:00pm

Article

Where does hope lie when it comes to improving the treatment landscape for rare cancers?

Blowing a Fuse: Fighting NTRK Gene Fusions in Cancer

August 30th 2019, 12:00am

Article

A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.

Friday Frontline: Cancer Updates, Research and Education on August 9, 2019

August 9th 2019, 5:00pm

Article

From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.

FDA Approves Turalio to Treat Tenosynovial Giant Cell Tumors

August 2nd 2019, 11:04pm

Article

The Food and Drug Administration approved Turalio to treat patients diagnosed with a group of rare, benign tumors.

FDA Grants Priority Review to Tazemetostat for Epithelioid Sarcoma

July 25th 2019, 5:46pm

Article

The Food and Drug Administration granted a priority review to a new drug application for the accelerated approval of tazemetostat to treat metastatic or locally advanced epithelioid sarcoma not eligible for curative surgery.